» Articles » PMID: 8288783

The Pathogenesis and Clinical Significance of Xanthelasma Palpebrarum

Overview
Specialty Dermatology
Date 1994 Feb 1
PMID 8288783
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Xanthelasma palpebrarum is the most common type of xanthoma. On average, only half the patients with xanthelasma palpebrarum are hyperlipidemic. This review is an attempt to elucidate the pathogenesis and clinical significance of xanthelasma palpebrarum, especially its suggested role as a marker for increased risk for atherosclerosis. In hyperlipidemic patients with xanthelasma, the risk for atherosclerosis may be inferred from the associated lipoprotein and apolipoprotein abnormalities. The possible risk for atherosclerosis in normolipidemic patients with xanthelasma is more obscure because of the relative paucity of epidemiologic data and the conflicting results in some of the lipid studies. Several studies, however, showed decreased high-density lipoprotein cholesterol levels and other lipoprotein and apolipoprotein abnormalities that are associated with atherosclerosis. Therefore, on the basis of the present data, determining the plasma lipoprotein and apolipoprotein levels (especially those associated with increased risk for atherosclerosis) in each normolipidemic patient with xanthelasma appears to be justified.

Citing Articles

Aesthetic Surgical Treatment of Large Xanthelasma palpebrarum.

Lin Y, Wu L Aesthetic Plast Surg. 2024; 48(23):4828-4832.

PMID: 39402201 PMC: 11739266. DOI: 10.1007/s00266-024-04435-x.


Examining treatment strategies for xanthelasma palpebrarum: a comprehensive literature review of contemporary modalities.

Yee D, Zhou A, Khachemoune A Arch Dermatol Res. 2024; 316(5):149.

PMID: 38724802 DOI: 10.1007/s00403-024-02863-y.


Genetic insight into putative causes of xanthelasma palpebrarum: a Mendelian randomization study.

Hu W, Liu Y, Lian C, Lu H Front Immunol. 2024; 15:1347112.

PMID: 38601164 PMC: 11004296. DOI: 10.3389/fimmu.2024.1347112.


Complete Blood Cell Count-Derived Inflammation Biomarkers in Patients with Xanthelasma Palpebrarum.

Berk Ergun S, Kurt B Beyoglu Eye J. 2024; 9(1):33-37.

PMID: 38504961 PMC: 10944854. DOI: 10.14744/bej.2024.48802.


Digital Patient Education on Xanthelasma Palpebrarum: A Content Analysis.

Varghese K, Singh S, Qureshi F, Shreekumar S, Ramprasad A, Qureshi F Clin Pract. 2023; 13(5):1207-1214.

PMID: 37887084 PMC: 10605081. DOI: 10.3390/clinpract13050108.